Smith, Lillian, et al. “The New Face of Hyperlipidemia Management: Proprotein Convertase Subtilisin Kexin Inhibitors (PCSK-9) and Their Emergent Role As An Alternative To Statin Therapy”. Journal of Pharmacy & Pharmaceutical Sciences, vol. 19, no. 1, Mar. 2016, pp. 137-46, doi:10.18433/J3J02P.